New skin cream GZ21T passes first safety check in healthy volunteers
NCT ID NCT06888362
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new cream called GZ21T in 41 healthy adults to see if it is safe and how the body absorbs it. The cream is being developed for actinic keratosis, a skin condition that can lead to cancer. No treatment was given; the goal was only to check for side effects and measure cream absorption.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTC (Clinical Trial Consultants) AB
Uppsala, Sweden, 75237, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Veterans' skin cancer risk may be cut by simple clinic procedures
- New test could prevent unnecessary surgery for common skin precancers
- New light device could spot skin cancer without a scalpel
- New ointment could zap Sun-Damaged skin lesions
- Can light detect skin cancer without a biopsy?
- New Light-Activated gel aims to clear precancerous skin spots